ArticleNanomaterials (Basel, Switzerland)2026
Nanoformulated
Almaha Al-Aqil, Ibrahim S Al Nasr, Hana Hakami, Faten Abou El Fadl, Chuanyi Wang, Mona Al-Shammari, Samiah Alotaibi, Sohaialah Alotaibi, Afnan Al-Qurashi, Huda Al-Rashid and 1 more
Abstract read
In one paragraphArticle in Nanomaterials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Almaha Al-AqilZoology Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0009-0009-0118-2778 Ibrahim S Al NasrDepartment of Biology, College of Science, Qassim University, Buraydah 52571, Saudi Arabia.ORCID 0000-0003-4690-1050 Hana HakamiZoology Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0009-0002-0790-0426 Faten Abou El FadlPolymer Chemistry Department, National Center for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority, Nasr City, P.O. Box 7551, Cairo 11762, Egypt.ORCID 0000-0001-5430-9554 Chuanyi WangSchool of Environmental Science and Engineering, Shaanxi University of Science and Technology, Xi'an 710021, China.
Mona Al-ShammariZoology Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
Samiah AlotaibiZoology Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0009-0009-2150-6928 Sohaialah AlotaibiZoology Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
Afnan Al-QurashiZoology Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0009-0002-0646-6488 Huda Al-RashidChair for Infectious Disease Vaccine Research, Zoology Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
Ebtesam Al-OlayanZoology Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0002-4041-9848 Funding
King Saud University ORF-2026-111
6 · The paper itselfAbstract
Cutaneous leishmaniasis remains a major therapeutic challenge due to drug toxicity, resistance, and limited efficacy against intracellular parasites. This study evaluated the therapeutic potential of nanoformulated
Indexed as
biocompatibilitycutaneous leishmaniasisdrug delivery systemshyaluronic acid nanoparticlesLeishmania majornanomedicinesilver nanoparticlestargeted therapyvenom-based therapyWalterinnesia aegyptia venom
Identifiers
PMID42188509
PMCPMC13209944
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390